- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
The company could soon see some tire kickers.
A possible merger between Nestle and Mead Johnson could trigger anti-trust concerns.
Pfizer is working on its eighth straight loss after failing near heavy resistance.
Shares of Pfizer have been on the decline, losing some 5% from its January 5 high of $33.61 a share.